← Open Payments lookup

SAMUEL MAYEDA: Open Payments

NPI 1487716544 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$551 in 23 payments from 18 companies in 2025. Trend: 2023 $1,276 · 2024 $965 · 2025 $551

Food & beverage: $551
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$81
Insulet Corporation1$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$40
Amgen Inc.2$34
IBSA Pharma Inc.2$34
Sandoz Inc.1$32
Bayer Healthcare Pharmaceuticals Inc.1$32
Exact Sciences Corporation1$31
ABBVIE INC.1$30
RECORDATI_RARE_DISEASES_INC.1$27

Products named: LEQVIO, Omnipod, JARDIANCE, REPATHA, Tirosint, Kerendia, Cologuard Collection Kit, QULIPTA.

Industry payments across CA — which companies pay providers there.